ATG5 and hepatocellular carcinoma: Although the Atg5 gene was shown to be not an optimal target gene for HCC RNAi therapy as its efficacy was weak, the validation using Atg5 had demonstrated the value of the AFP-Cre/LoxP-shRNA system.